Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of the rat

被引:7
作者
Giuliana Silvestrini
Paola Ballanti
Francesca Patacchioli
Martina Leopizzi
Novella Gualtieri
Paola Monnazzi
Elisa Tremante
Daniela Sardella
Ermanno Bonucci
机构
[1] Policlinico Umberto I,Department of Experimental Medicine and Pathology, Sezione di Anatomia Patologica
[2] University of Rome,Human Physiology and Pharmacology
[3] University of Rome,Clinical Sciences, “La Sapienza”
来源
Journal of Molecular Histology | 2005年 / 36卷
关键词
Receptor Activator; Nuclear Factor; Bone Metabolism; Serial Section; Bone Cell;
D O I
暂无
中图分类号
学科分类号
摘要
Osteoprotegerin (OPG) and the receptor activator of nuclear factor (NF)-kB ligand (RANKL) are key regulators of osteoclastogenesis. The present study had the main aim of showing the localization of OPG and RANKL mRNA and protein in serial sections of the rat femurs and tibiae by immunohistochemistry (IHC) and in situ hybridization (ISH). The main results were: (1) OPG and RANKL mRNA and protein were co-localized in the same cell types, (2) maturative/hypertrophic chondrocytes, osteoblasts, lining cells, periosteal cells and early osteocytes were stained by both IHC and ISH, (3) OPG and RANKL proteins were mainly located in Golgi areas, and the ISH reaction was especially visible in active osteoblasts, (4) immunolabeling was often concentrated into cytoplasmic vacuoles of otherwise negative proliferative chondrocytes; IHC and ISH labeling increased from proliferative to maturative/hypertrophic chondrocytes, (5) the newly laid down bone matrix, cartilage-bone interfaces, cement lines, and trabecular borders showed light OPG and RANKL immunolabeling, (6) about 70% of secondary metaphyseal bone osteocytes showed OPG and RANKL protein expression; most of them were ISH-negative, (7) osteoclasts were mostly unstained by IHC and variably labeled by ISH. The co-expression of OPG and RANKL in the same bone cell types confirms their strictly coupled action in the regulation of bone metabolism.
引用
收藏
页码:59 / 67
页数:8
相关论文
共 229 条
[1]  
Anderson DM(1997)A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function Nature 390 175-179
[2]  
Maraskovsky E(2000)Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation Bone 26 653-661
[3]  
Billingsley WL(2002)Clonal endothelial cells produce humoral factors that inhibit osteoclast-like cell formation in vitro J Endocrinol 49 439-447
[4]  
Dougall WC(2001)Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques Arterioscler Thromb Vasc Biol 21 1998-2003
[5]  
Tometsko ME(2003)Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear-kB ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2 J Biol Chem 278 23971-23977
[6]  
Roux ER(2000) mice by RANKL transgene J Bone Min Res 15 2-12
[7]  
Teepe MC(1999)The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption Proc Natl Acad Sci USA 96 3540-3545
[8]  
DuBose RF(2001)Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand J Bone Miner Res 16 1416-1425
[9]  
Cosman D(1999)Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones Bone 25 525-534
[10]  
Galibert L(2001)Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues Arthritis Rheum 44 2768-2776